Wechsle zur englischsprachigen Webseite

Welcome to the Health Data Lab

The Health Data Lab (HDL) at the Federal Institute for Drugs and Medical Devices makes pseudonymised billing data from people insured in the statutory health system available for research purposes with the goal of improving healthcare for all.

 

Research Highlights

Research for optimal healthcare

The Health Data Lab (HDL) allows researchers to analyse healthcare data from people insured within the statutory health system in Germany. With the aim of making this data utilisable for research purposes, the HDL makes an important contribution towards better healthcare.

The HDL receives the billing data annually in pseudonymised form from the German National Association of Health Insurance Funds. General information on the data available at the HDL and its protection can be found under Health Data.

Learn more

 

Analyses based on HDL data result in a wide range of scientific publications that help to improve the medical care people receive.
The data is transmitted in pseudonymised form to the HDL. In such a case, the data can no longer be assigned to a specific person without the addition of further information.
Only authorised institutions will have access to HDL data. These include, e.g. healthcare research institutions and key federal organisations for the representation of patients' interests (cf. Section 303e SGB V).
New methods such as machine learning or the use of artificial intelligence are also gaining ground in the medical field to the benefit of patients. The HDL also plays a crucial role in this development.

Research | Public Health data at the HDL

Find out how the HDL handles healthcare data – starting with protection against identification through pseudonymisation, up to data protection issues and data security.
Learn more

Research | Public Research & Digitalisation

Digitalisation offers great opportunities for the optimal care of people, the development of new therapies and the provision of efficient healthcare.
Learn more